Literature DB >> 32276543

Three-dimensional models of breast cancer-fibroblasts interactions.

Sunil Singh1, Sydnie Tran1, Justin Putman1, Hossein Tavana1.   

Abstract

IMPACT STATEMENT: Tumor stroma plays an important role in progression of cancers to a fatal metastatic disease. Modern treatment strategies are considering targeting tumor stroma to improve outcomes for cancer patients. A current challenge to develop stroma-targeting therapeutics is the lack of preclinical physiologic tumor models. Animal models widely used in cancer research lack human stroma and are not amenable to screening of chemical compounds for cancer drug discovery. In this review, we outline in vitro three-dimensional tumor models that we have developed to study the interactions among cancer cells and stromal cells. We describe development of the tumor models in a modular fashion, from a spheroid model to a sophisticated organotypic model, and discuss the importance of using correct physiologic models to recapitulate tumor-stromal signaling. These biomimetic tumor models will facilitate understanding of tumor-stromal signaling biology and provide a scalable approach for testing and discovery of cancer drugs.

Entities:  

Keywords:  Tumor microenvironment; breast cancer; cancer-associated fibroblasts; tumor model

Mesh:

Year:  2020        PMID: 32276543      PMCID: PMC7268931          DOI: 10.1177/1535370220917366

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  78 in total

1.  Coevolution of cancer and stromal cellular responses.

Authors:  Laurie E Littlepage; Mikala Egeblad; Zena Werb
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

Review 2.  Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling.

Authors:  Pradip Shahi Thakuri; Chun Liu; Gary D Luker; Hossein Tavana
Journal:  Adv Healthc Mater       Date:  2017-12-04       Impact factor: 9.933

3.  Organotypic breast tumor model elucidates dynamic remodeling of tumor microenvironment.

Authors:  Sunil Singh; Lucille A Ray; Pradip Shahi Thakuri; Sydnie Tran; Michael C Konopka; Gary D Luker; Hossein Tavana
Journal:  Biomaterials       Date:  2020-02-07       Impact factor: 12.479

4.  Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854).

Authors:  T J A Dekker; C J H van de Velde; G W van Pelt; J R Kroep; J-P Julien; V T H B M Smit; R A E M Tollenaar; W E Mesker
Journal:  Breast Cancer Res Treat       Date:  2013-05-25       Impact factor: 4.872

5.  Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer.

Authors:  Xiongyan Wu; Xuehua Chen; Quan Zhou; Pu Li; Beiqin Yu; Jianfang Li; Ying Qu; Jun Yan; Yingyan Yu; Min Yan; Zhenggang Zhu; Bingya Liu; Liping Su
Journal:  Cancer Lett       Date:  2013-02-09       Impact factor: 8.679

Review 6.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

7.  FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.

Authors:  Rachel Sharpe; Alex Pearson; Maria T Herrera-Abreu; Damian Johnson; Alan Mackay; Jonathan C Welti; Rachael Natrajan; Andrew R Reynolds; Jorge S Reis-Filho; Alan Ashworth; Nicholas C Turner
Journal:  Clin Cancer Res       Date:  2011-06-28       Impact factor: 12.531

8.  Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis.

Authors:  Shiaw-Wei Tyan; Wen-Hung Kuo; Chun-Kai Huang; Chi-Chun Pan; Jin-Yuh Shew; King-Jen Chang; Eva Y-H P Lee; Wen-Hwa Lee
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

9.  Evidence that breast tissue stiffness is associated with risk of breast cancer.

Authors:  Norman F Boyd; Qing Li; Olga Melnichouk; Ella Huszti; Lisa J Martin; Anoma Gunasekara; Gord Mawdsley; Martin J Yaffe; Salomon Minkin
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

10.  The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.

Authors:  F J A Gujam; J Edwards; Z M A Mohammed; J J Going; D C McMillan
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

View more
  2 in total

1.  Therapeutic Targeting of Stromal-Tumor HGF-MET Signaling in an Organotypic Triple-Negative Breast Tumor Model.

Authors:  Sunil Singh; Astha Lamichhane; Pouria Rafsanjani Nejad; Jacob Heiss; Hannah Baumann; Ravindra Gudneppanavar; Nic D Leipzig; Michael Konopka; Gary D Luker; Hossein Tavana
Journal:  Mol Cancer Res       Date:  2022-07-06       Impact factor: 6.333

2.  A novel tumor-immune microenvironment (TIME)-on-Chip mimics three dimensional neutrophil-tumor dynamics and neutrophil extracellular traps (NETs)-mediated collective tumor invasion.

Authors:  Vikram Surendran; Dylan Rutledge; Ramair Colmon; Arvind Chandrasekaran
Journal:  Biofabrication       Date:  2021-04-08       Impact factor: 9.954

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.